Patent · US Active

Substituted anilines as CCR(4) antagonists

US9758512B2 · kind B2 · utility

5Cited by

1References

24Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Trevor T. Charvat · San Jose, US
Junfa Fan · Palo Alto, US
Christopher W. Lange · Hayward, US
Manmohan Reddy Leleti · Sunnyvale, US
Yandong Li · San Jose, US
Venkat Reddy Mali · Cupertino, US
Jeffrey P. McMahon · San Francisco, US
Jay P. Powers · Pacifica, US
Sreenivas Punna · Sunnyvale, US
Ju Yang · Palo Alto, US

Key dates

Filing date	Jul 11, 2016
Grant date	Sep 12, 2017
Priority date	—
Expiry date	Jul 11, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Aniline compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.